Triveni Bio
Jennifer Dovey has a background in genetics and a Ph.D. in Genetics from Harvard University. Jennifer has held various positions focusing on drug discovery and development in biotech and pharmaceutical companies. Jennifer has experience in leading research projects, developing novel antibody therapies, and managing cross-functional teams. Jennifer has also conducted research on cancer pathways and stem cells during their time as a postdoctoral fellow at the David H. Koch Institute for Integrative Cancer Research @ MIT. Jennifer is currently the Chief Scientific Officer at Triveni Bio.
This person is not in any teams
Triveni Bio
Triveni Bio is a biotech company pioneering a genetics-informed precision medicine approach to develop functional antibodies for the treatment of I&I disorders. The company’s approach establishes proof-of-concept at the earliest stages of drug development. Through a strong understanding of genetics and mechanistic biology, our pipeline is powered for indication expansion where we know we can have the most impact. To learn more, visit www.triveni.bio.